Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma

[1]  David A. Brenner,et al.  Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways , 2006 .

[2]  S. Thorgeirsson,et al.  A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells , 2006, Nature Medicine.

[3]  P. Chambon,et al.  Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling. , 2006, Human molecular genetics.

[4]  G. Farrell,et al.  Nonalcoholic fatty liver disease: From steatosis to cirrhosis , 2006, Hepatology.

[5]  M. Uribe,et al.  Hepatocellular carcinoma. An overview. , 2006, Annals of hepatology.

[6]  M. Alison,et al.  Liver cancer: the role of stem cells , 2005, Cell proliferation.

[7]  Michael Karin,et al.  IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis , 2005, Cell.

[8]  G. Courtois.  The NF-κB signaling pathway in human genetic diseases , 2005, Cellular and Molecular Life Sciences CMLS.

[9]  T. Luedde,et al.  Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury. , 2005, The Journal of clinical investigation.

[10]  T. Roskams,et al.  Preneoplastic lesions in human hepatocarcinogenesis , 2005, Liver international : official journal of the International Association for the Study of the Liver.

[11]  G. Gores,et al.  The Relationship Between Apoptosis and Non-Alcoholic Fatty Liver Disease: An Evolutionary Cornerstone Turned Pathogenic , 2005, Zeitschrift fur Gastroenterologie.

[12]  S. Vowler,et al.  Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. , 2005, Gastroenterology.

[13]  T. Roskams,et al.  Early hepatocellular carcinoma and dysplastic nodules. , 2005, Seminars in liver disease.

[14]  M. Sherman.  Hepatocellular carcinoma: epidemiology, risk factors, and screening. , 2005, Seminars in liver disease.

[15]  Y. Ben-Neriah,et al.  NF-κB functions as a tumour promoter in inflammation-associated cancer , 2004, Nature.

[16]  Wei Zhang,et al.  Function of oval cells in hepatocellular carcinoma in rats. , 2004, World journal of gastroenterology.

[17]  S. Locarnini.  Molecular virology of hepatitis B virus. , 2004, Seminars in liver disease.

[18]  P. Vandenabeele,et al.  Bcl-2 Family Members as Sentinels of Cellular Integrity and Role of Mitochondrial Intermembrane Space Proteins in Apoptotic Cell Death , 2003, Acta Haematologica.

[19]  M. Karin,et al.  IKKβ Is Required for Prevention of Apoptosis Mediated by Cell-Bound but Not by Circulating TNFα , 2003 .

[20]  J. Burke.  Targeting I kappa B kinase for the treatment of inflammatory and other disorders. , 2003, Current opinion in drug discovery & development.

[21]  S. Yamashita,et al.  Bax cleavage implicates caspase-dependent H2O2-induced apoptosis of hepatocytes. , 2003, International journal of molecular medicine.

[22]  Christian Trautwein,et al.  Losing balance: cytokine signaling and cell death in the context of hepatocyte injury and hepatic failure. , 2003, European cytokine network.

[23]  N. Fausto,et al.  Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy. , 2002, The Journal of clinical investigation.

[24]  N. Enomoto,et al.  Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-alpha production. , 2002, Gastroenterology.

[25]  G. Courtois,et al.  TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2 , 2002, Nature.

[26]  L. Gresh,et al.  Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1beta. , 2002, Development.

[27]  M. Karin,et al.  Missing Pieces in the NF-κB Puzzle , 2002, Cell.

[28]  Michael Karin,et al.  NF-κB at the crossroads of life and death , 2002, Nature Immunology.

[29]  J. Romijn,et al.  Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats. , 2001, Diabetes.

[30]  T. Roskams,et al.  Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non‐cirrhotic and cirrhotic chronic viral hepatitis , 2001, Histopathology.

[31]  G. Ramadori,et al.  Cytokines in the liver. , 2001, European journal of gastroenterology & hepatology.

[32]  John Calvin Reed,et al.  Inhibition of the NF-κB transcription factor increases Bax expression in cancer cell lines , 2001, Oncogene.

[33]  Klaus Rajewsky,et al.  NEMO/IKKγ-Deficient Mice Model Incontinentia Pigmenti , 2000 .

[34]  V. Godfrey,et al.  Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti. , 2000, Molecular cell.

[35]  Steffen Jung,et al.  High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation , 2000, Nature Medicine.

[36]  T. Mak,et al.  Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice. , 2000, Genes & development.

[37]  C. Kellendonk,et al.  Hepatocyte‐specific expression of Cre recombinase , 2000, Genesis.

[38]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[39]  H. Otto,et al.  “Slow-down” of the intrahepatic bile duct development between the 2nd and the 3rd trimester of gestation , 2000 .

[40]  G. Gao,et al.  N‐terminal cleavage of Bax by calpain generates a potent proapoptotic 18‐kDa fragment that promotes Bcl‐2‐independent cytochrome C release and apoptotic cell death , 2000, Journal of cellular biochemistry.

[41]  H. Hemmerle,et al.  Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats. , 1999, European journal of pharmacology.

[42]  H. Pahl.  Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.

[43]  M. Karin.  How NF-κB is activated: the role of the IκB kinase (IKK) complex , 1999, Oncogene.

[44]  T. Deerinck,et al.  The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis , 1999, The Journal of experimental medicine.

[45]  A. Strasser,et al.  FADD/MORT1, a signal transducer that can promote cell death or cell growth. , 1999, The international journal of biochemistry & cell biology.

[46]  Inder M. Verma,et al.  Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene , 1999 .

[47]  D. Goeddel,et al.  Embryonic Lethality, Liver Degeneration, and Impaired NF-κB Activation in IKK-β-Deficient Mice , 1999 .

[48]  J. Belghiti,et al.  [Association of hepatic adenomatosis and hepatoportal sclerosis in a woman with incontinentia pigmenti]. , 1997, Gastroenterologie clinique et biologique.

[49]  G. Kollias,et al.  Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response , 1996, The Journal of experimental medicine.

[50]  I. Wanless,et al.  Terminology of nodular hepatocellular lesions , 1995 .

[51]  David Baltimore,et al.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB , 1995, Nature.

[52]  S. Genet,et al.  Interaction of incontinentia pigmenti and factor VIII mutations in a female with biased X inactivation, resulting in haemophilia. , 1993, Journal of medical genetics.

[53]  T. Mak,et al.  Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection , 1993, Cell.